Juvenile recurrent respiratory papillomatosis treated with systemic bevacizumab: A single-center pediatric case series.
BACKGROUND Juvenile recurrent respiratory papillomatosis (JRRP) is a rare and potentially life-threatening disease caused by human papillomavirus (HPV) infection, most commonly types 6 and 11. Despite repeated surgical interventions, disease recurrence is frequent, and there is no curative treatment. Bevacizumab, a mon...